Dr. Fenning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
9 Gates
Philadelphia, PA 19104Phone+1 215-662-2884
Education & Training
- University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2011 - 2014
- University of Pennsylvania Health SystemResidency, Internal Medicine, 2008 - 2011
- Perelman School of Medicine at the University of PennsylvaniaClass of 2008
Certifications & Licensure
- NJ State Medical License 2015 - 2025
- PA State Medical License 2008 - 2024
- LA State Medical License 2015 - 2016
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 294 citationsInhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque developmentRobert L. Wilensky, Yi Shi, Emile R. Mohler, Damir Hamamdzic, Mark E. Burgert
Nature Medicine. 2008-10-01 - 17 citationsAtherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2.Robert S. Fenning, Mark E. Burgert, Damir Hamamdzic, Eliot G Peyster, Emile R. Mohler
Journal of the American Heart Association. 2015-02-24 - 25 citationsSubsequent Development of Fibroatheromas With Inflamed Fibrous Caps Can Be Predicted by Intracoronary Near Infrared SpectroscopyDhavalkumar Patel, Damir Hamamdzic, Raul Llano, Daivesh Patel, Lan Cheng
Arteriosclerosis, Thrombosis, and Vascular Biology. 2013-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: